Literature DB >> 19359812

QRS prolongation is associated with high defibrillation thresholds during cardioverter-defibrillator implantations in patients with hypertrophic cardiomyopathy.

Takayuki Nagai1, Takashi Kurita, Kazuhiro Satomi, Takashi Noda, Hideo Okamura, Wataru Shimizu, Kazuhiro Suyama, Naohiko Aihara, Junjiro Kobayashi, Shiro Kamakura.   

Abstract

BACKGROUND: Although high defibrillation threshold (DFT) is a major and unavoidable clinical problem after implantation of an implantable cardioverter defibrillator (ICD), little is known about the cause and management of a high DFT in patients with hypertrophic cardiomyopathy (HCM). The purpose of this study was to assess the predictors of a high DFT in patients with HCM. METHODS AND
RESULTS: Twenty-three patients with non-dilated HCM who underwent ICD implantation were included. The DFT at the time of the device implantation was measured in all patients. The patients were divided into 2 groups, a high DFT group (DFT >or=15J, n=13) and a low DFT group (DFT <15J, n=10); and their baseline characteristics were compared. The QRS duration was longer in the high than in the low DFT group (128 +/-31 vs 103 +/-12 ms, respectively; P=0.02). QRS duration, left ventricular (LV) end-systolic diameter, and LV ejection fraction were significant predictors of DFT in univariate analysis. However, in multivariate analysis, the only factor significantly associated with DFT was QRS duration (P=0.002).
CONCLUSIONS: QRS duration is the most consistent predictor of a high DFT in HCM patients undergoing ICD implantation.

Entities:  

Mesh:

Year:  2009        PMID: 19359812     DOI: 10.1253/circj.cj-08-0744

Source DB:  PubMed          Journal:  Circ J        ISSN: 1346-9843            Impact factor:   2.993


  6 in total

1.  Effect of substance abuse on defibrillation threshold in patients with implantable cardioverter-defibrillator.

Authors:  Shane A Perrine; Raghavendra Nayak; Aditya S Bharadwaj; George McKelvey; Tamam Mohamad; Sony Jacob
Journal:  Pacing Clin Electrophysiol       Date:  2010-10-14       Impact factor: 1.976

2.  Azygos vein lead implantation for high defibrillation thresholds in implantable cardioverter defibrillator placement.

Authors:  Naga Va Kommuri; Sri Lakshmi S Kollepara; E Saulitis; Ma Siddiqui
Journal:  Indian Pacing Electrophysiol J       Date:  2010-01-07

3.  How to Manage a High Defibrillation Threshold in ICD Patients: and Does it Really Matter?

Authors:  Maria Vittoria Matassini; Jeff S Healey
Journal:  Curr Treat Options Cardiovasc Med       Date:  2013-08

4.  Fabry cardiomyopathy presenting with a high defibrillation threshold: A short case report.

Authors:  Takashi Kanda; Masaharu Masuda; Akihiro Sunaga; Masashi Fujita; Osamu Iida; Shin Okamoto; Takayuki Ishihara; Kiyonori Nanto; Tatsuya Shiraki; Fusako Sera; Masaaki Uematsu
Journal:  J Arrhythm       Date:  2014-12-02

Review 5.  Hypertrophic cardiomyopathy: Can the noninvasive diagnostic testing identify high risk patients?

Authors:  Li Zhang; Obinna Mmagu; Liwen Liu; Dayuan Li; Yuxin Fan; Adrian Baranchuk; Peter R Kowey
Journal:  World J Cardiol       Date:  2014-08-26

6.  High defibrillation threshold: the science, signs and solutions.

Authors:  Sony Jacob; Victorio Pidlaoan; Jaspreet Singh; Aditya Bharadwaj; Mehul B Patel; Antonio Carrillo
Journal:  Indian Pacing Electrophysiol J       Date:  2010-01-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.